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PENGASINGAN DAN PENCIRIAN BAKTERIOFAJ DARI SISA KUMBAHAN 
KHUSUS PADA Escherichia coli O157:H7 
 
ABSTRAK 
 
 
 
 Faj khusus pada E. coli O157:H7 telah berjaya diasingkan untuk pertama 
kalinya di Malaysia dari kemudahan sisa kumbahan dalam kampus Universiti Sains 
Malaysia di Pulau Pinang.  Berdasarkan kajian morfologi, faj ini dipercayai adalah 
faj-menyerupai T4 yang tergolong dalam keluarga Myoviridae; begitu juga seperti faj 
khusus pada E. coli O157:H7 lain yang pernah diasingkan sebelum ini. Ciri 
fizikokimia faj ini menunjukkan ia dapat menjangkiti bakteria pada julat suhu 
daripada 10 °C kepada 37 °C, julat pH dari pH 5 hingga pH 10 dan julat kepekatan 
garam dari 0.17 M kepada 0.3 M. Faj khusus pada E. coli O157:H7 yang telah 
diasingkan ini mempunyai spektrum tuan rumah yang sempit kerana ia hanya dapat 
menjangkiti satu  hanya satu strain E. coli (E. coli ATCC 13706), daripada dua belas 
bacteria yang berbeza (Enterobacteriaceae dan bukan Enterobacteriaceae) yang 
diuji. Kajian separa genomik menunjukkan ia mempunyai perkongsian identiti yang 
tinggi dengan Enterobakteria faj RB69, dan HX01 yang masing-masing telah 
diasingkan dari sisa kumbahan di Amerika Syarikat dan najis itik di China.  Yang 
menghairankan, sel rumah bagi kedua-dua faj adalah bukan E. coli O157:H7 iaitu E. 
coli strain B untuk RB69 dan avian patogenik E. coli (APEC) untuk HX01. 
Perbandingan genomik selanjutnya antara faj yang diasingkan dengan RB69 (sama 
dengan kebanyakan urutan klon) menunjukkan corak profail enzim penghadaman 
yang berbeza walau pun kedua-duanya adalah  faj-menyerupai T4 yang tergolong 
xviii 
 
dalam keluarga Myoviridae.  Di samping itu, analisis protein separa menunjukkan 
bahawa faj yang diasingkan ini mempunyai profail protein yang berbeza daripada faj 
T4 dan T7, dua faj lazim berekor. Oleh itu, kajian ini menyediakan potensi 
pertambahan kepada faj yang terasing, khususnya faj khusus kepada E. coli O157:H7 
dari sisa kumbuhan daripada Malaysia. Kajian berkenaan ciri-ciri faj ini 
berkemungkinan menyumbang kepada pengetahuan yang boleh digunakan untuk 
pembangunan agen kawalan bio terhadap E. coli O157:H7. 
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ISOLATION AND CHARACTERIZATION OF BACTERIOPHAGE FROM RAW 
SEWAGE SPECIFIC FOR Escherichia coli O157:H7 
 
ABSTRACT 
 
 
 E. coli
 
O157:H7-specific phage was successfully isolated for the first time in 
Malaysia, from a sewage facility of Universiti Sains Malaysia campus in Penang.  
Based on morphological study, the isolated phage was suggested to be a T4-like 
phage belonging to Myoviridae family; similar to other E. coli
 
O157:H7-specific 
phages previously isolated. Physicochemical properties of the isolated phage indicate 
infective (able to replicate) at temperature range from 10 °C to 37 °C, pH range from 
pH 5 to pH 10 and salt concentration range from 0.17 M to 0.3 M.  The isolated E. 
coli
 
O157:H7-specific phage had a narrow host range as it was able to infect only one 
strain of E. coli (E. coli ATCC 13706), out of twelve different bacteria 
(Enterobacteriaceae and non-Enterobacteriaceae) tested.  Partial genomic studies 
demonstrated high degree of identity sharing with Enterobacteria phage RB69 and 
HX01 which was isolated from raw sewage in the U.S. and duck faeces in China, 
respectively. The host for both phages are non E. coli O157:H7 which is E. coli B 
strain for RB69 and avian pathogenic E. coli (APEC) strains, for HX01. Further 
genomic comparison between the isolated phage and RB69 (similar with most of 
clone sequences) showed different restriction enzyme pattern profiling though both 
of them are T4-like phage in the same family, Myoviridae. Besides, partial protein 
analysis revealed that the isolated phage displayed distinctive protein profile 
compared with phage T4 and T7. Hence, this study provides a potential addition to 
xx 
 
the growing number of phages discovered, specifically E. coli O157:H7-specific 
phages from raw sewage from Malaysia.  The studies on its characterizations may 
provide knowledge that could be useful for the development of bio-control agent 
against E. coli O157:H7. 
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CHAPTER 1 
 
INTRODUCTION 
 
 
 
 Bacteriophages or phages for short are viruses infecting specific bacteria.  
Phages are among the most common biological entities on earth and are found in all 
habitats in the world where bacteria and archaea proliferate (Clokie et al., 2011).  
Being the most widely distributed biological entity in the biosphere, phage 
population is greater than 10
31
 or approximately 10 million per cubic centimeter 
(Kwiatek et al., 2012). Recent estimates suggest that there exist globally ~100 
million phage species; however, only a small fraction of phages have so far been 
characterized with around 6000 have been identified and reported towards the end of 
last century (Ackermann, 2000).  Thus, this means, many phages are waiting to be 
discovered. 
 
The notorious E. coli O157:H7 is an enterohaemorrhagic strain of E. coli 
(EHEC) recognized as the most important EHEC causing hemorrhagic diarrheal and 
kidney failure via food contamination (Goncuoglu et al., 2010).  The bacteria could 
be found in the lower intestinal tracts of human, free-living animals and warm-
blooded organisms (Vogt & Dippold, 2005). The bacterium is also found in water, 
foods and soil due to contamination of faecal or during animal slaughter (Schroeder 
et al., 2002). 
 
Among the discovered phages, they are phages specific to E. coli O157.  Up 
till now, there are more than fifty E. coli O157-specific phages have been discovered 
by previous researchers and twenty four of them are highly specific against E. coli 
O157:H7.  However, only six of the E. coli O157:H7-specific phages have been 
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isolated from Asia regions and the rest are from North America countries.  Majority 
of the isolated E. coli O157:H7-specific phages are from faecal sample with one 
from salt water sample and two from industrial wastewater.  Currently, there is no 
record of E. coli O157:H7-specific phage ever been isolated from Southeast Asia 
region.  Therefore, an attempt was made to isolate E. coli O157:H7-specific phage 
from raw sewage sample of sewage treatment facility in Penang, Malaysia. 
 
Every E. coli O157:H7-specific phages isolated so far shows variations, as 
well as, similarities among them that contribute to phage diversities.  Hence, the 
isolated E. coli O157:H7-specific phage from raw sewage in Penang, Malaysia could 
as well possibly show variations and similarities to previously isolated E. coli 
O157:H7-specific phages and might have the potential as an addition to the ICTV 
database.  The basic understanding of phage biology of the isolated E. coli O157:H7-
specific phage could be useful for the development of bio-control agent against E. 
coli O157:H7.  Due to the emergence of antibiotic resistant bacteria, natural control 
strategies have received growing demand and attention including the application of 
phages as bio-control agents (Coffey et al., 2011). 
 
Thus, the main purposes of this project were to isolate and characterize E. 
coli O157:H7-specific phage from raw sewage sample.  The specific objectives of 
this work were: 
1) To isolate E. coli O157:H7-specific phage from raw sewage. 
2) To characterize the isolated E. coli O157:H7-specific phage based on: 
a) morphological study. 
b) physical chemical attributes (temperature, pH and salinity). 
c) phage-host interaction specificity. 
d) partial molecular identification using genomic and proteomic 
approaches. 
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CHAPTER 2 
LITERATURE REVIEW 
 
 
 
 
2.1 Viruses in general  
 
 The word virus came from the Latin meaning “slimy liquid” or “poison” 
referring to poisonous and lethal substance (Pelczar et al., 2010; Black, 2012). 
Viruses are often defined as obligate intracellular parasites that can only replicate 
dependently inside the host organisms (Koonin et al., 2006).  Viruses could have 
only one type of genetic material, either DNA or RNA, which depend upon hosts to 
carry out their replication cycles for the production of new virions.  They would 
inject their genomes into suitable living host cells via inhalation, direct contact and 
ingestion (Madigan et al., 2010).  Since viruses have no ability to metabolize on their 
own, they have the capabilities of becoming parasites on the host cells for almost all 
of their life-sustaining functions. Once they are inside, they would gain control of the 
hosts and produce all necessary molecules before assembling and releasing new 
virions that lead to the disruption in cell functions (Rybicki, 1990; Clark & March, 
2006). 
 
 Viruses are thought to be the smallest form of entities on earth and they do 
not respire, grow or divide. They are measured in nanometer (nm) compare to 
bacteria which is in micrometer (µm) size. Suffice to say, viruses are 100 times 
smaller than bacteria (Shors, 2013). By reason of their sizes, viruses cannot be 
observed with a basic optical microscope, hence, scanning and transmission electron 
microscopes are the only way to visualize them (Collier, 2011).  Overall, majority of 
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viruses fall in the range of 30 to 90 nm in measurement. However, the largest known 
virus is Mimivirus with the size of could be up to 400 nm while Parvovirus, 
considered as one of the smallest viruses, could be measured as small as 18 nm in 
dimension (Dimmock et al., 2007; Shors, 2013). 
 
 The kinds of genomes separate the viruses into two main groups which are 
DNA viruses and RNA viruses.  Each group is further topologically divided into 
single-stranded or double-stranded, linear or circular forms (Metzler & Metzler, 
2001; Madigan et al., 2010). These genome types would depend on the viruses, 
which made them unique and different from other organisms. The basic structure of a 
virus is shown in Figure 2.1. 
 
 In viral taxonomy, viruses are grouped according to their equivalence 
properties such as size, nucleic acid type and topology, capsid structure and 
symmetry, presence or absence of an envelope, host range and immunological 
characteristics (Christian, 2002). They are classified into two complementary 
systems for standardize identification purposes.  In 1996, the International 
Committee on Taxonomy of Viruses (ICTV) has established a single comprehensive 
scheme for classification of all viruses into order, family, genera and species based 
on Linnaean hierarchy system with current standing at 7 orders and 96 families 
(Hurst, 2000; Delwart, 2007; King et al., 2011).  On the other hand, the Baltimore 
system provides a helpful guide in virus classification based on the unique method of 
viral genome replication strategy (Christian, 2002; Hogan et al., 2005) that 
categorize viruses into seven different classes based on virus’s nucleic acid type and 
topology (Dimmock et al., 2007). 
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Figure 2.1: Basic structure of a virus.  The nucleic acid genomes could be 
either DNA or RNA.  The nucleic acid genome is protected by protein coat or 
capsid that is made up of a finite number of protein subunits called 
capsomeres.  A lipid membrane or envelope provides additional protection to 
the nucleic acid genome.  The presence of   protein spikes embedded in the 
envelope serve as attachment point to the host cell (Williams, 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lipid envelope 
Protein spikes 
Nucleic acid 
genomes 
Protein 
capsomeres 
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2.2 Bacteriophages 
 
 Bacteriophages or phages for short are bacterial viruses that are highly 
specific in their host-cell recognition infecting only targeted bacteria species or 
strains (Clark & March, 2006; Hagens & Loessner, 2007; Hanlon, 2007; Nishikawa 
et al., 2008; Viazis et al., 2011). They are also considered as natural predators of 
bacteria that cause lysis of the infected host cells (Abuladze et al., 2008; Nishikawa 
et al., 2008). 
 
 
  ICTV presently classifies viruses into 7 orders and 96 families. Within this 
system, phage is placed into only one order, Caudovirales, 13 families and 30 genera 
(Ackermann, 2003; Ackermann, 2011).  The prominent members of the 
Caudovirales are grouped into three large families: Myoviridae, Siphoviridae and 
Podoviridae. All phages constituted in these families have non-enveloped 
icosahedral heads but differ in their tail length and contractile ability (Ackermann, 
1998).  Up to now, most of the identified phages are tailed phages with isometric 
heads containing double-stranded DNA (Ackermann, 2003; Hagens & Loessner, 
2007; Ackermann; 2011).  
 
Phages belong to Myoviridae family are characterized by their long 
contractile tails consisting of a sheath (Ackermann, 2003; O’Flaherty et al., 2004; 
Ackermann, 2011).  Examples of phages in this family are T4, P1, P2, SP01 and Mu-
like viruses (Ackermann, 2003; O’Flaherty et al., 2004; Lavigne et al., 2009). The 
genome size of these phages distinctly varies but a complete genome sequence has 
7 
 
revealed that the T4-related phages represent one of the largest phages (Lavigne et 
al., 2009). 
 
Among the tailed phages, 61% have long and non-contractile tails which 
belong to Siphoviridae (Ackermann, 2003).  Examples of phages in this family are 
lambda () and T5-like viruses (Ackermann, 1998; Grabow, 2001; Ackermann, 
2003; Ackermann, 2011). Besides, the majority of the known tailed phages belong to 
this family (Ackermann, 2003). 
 
Unlike the other families, Podoviridae phages have short and non-contractile 
tails (Ackermann, 1998; Grabow, 2001; Ackermann, 2003; Ackermann, 2011) such 
as T7-like viruses. 
 
Figure 2.2 shows the comparison in structure of these three families 
Myoviridae, Siphoviridae and Podoviridae. Based on the ICTV classification, the 
phages are placed according to their respective order, families, genome type and size 
as shown in Table 2.1. 
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Myoviridae Podoviridae Siphoviridae 
Figure 2.2: Comparison of three family members of Caudovirales;  Myoviridae, 
Podoviridae and Siphoviridae families (Harper, 2011). 
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Virus family Genome type Genome 
size (kb) 
Structure Example 
Caudovirales 
 
Myoviridae dsDNA 33.6-170 Non-enveloped, icosahedral head (50-110 nm, 
may be elongated) with long contractile tail 
Enterobacteria phage T4 
Podoviridae dsDNA 40-42+ Non-enveloped, icosahedral head (60 nm) 
with short, non-contractile tail 
Enterobacteria phage T7 
Siphoviridae dsDNA 48.5 Non-enveloped, icosahedral head (60 nm) 
with long, non-contractile tail 
Enterobacteria phage  
Other families 
 
Tectiviridae dsDNA 147-157 Icosahedral, contains lipid, 63 nm with 20 nm 
spikes 
Enterobacteria phage 
PRD1 
Corticoviridae dsDNA 9-10 Icosahedral, contains lipid 60 nm+ Pseudoalteromonas 
phage PM2 
Plasmaviridae dsDNA 12 Enveloped, spherical/pleomorphic, 80 nm Acholeplasma phage L2 
Inoviridae ssDNA 4.4-8.5 Non-enveloped, filamentous, 6-8 nm x 760-
1950 nm 
Enterobacteria phage 
M13 
Microviridae ssDNA 4.4-5.4 Non-enveloped, icosahedral, 25-27 nm Enterobacteria phage 
ϕX174 
Leviviridae ssDNA 3.4-4.2 Non-enveloped, icosahedral, 26 nm Enterobacteria phage 
MS2 
Cystoviridae dsRNA 
(segmented) 
13.4 
(3segments) 
Enveloped, spherical, 86 nm with 8 nm spikes Pseudomonas phage ϕ6 
Table 2.1 ICTV classification of phages (Harper, 2011). 
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2.2.1 The lytic and lysogenic cycle 
 
 
 
 Different bacteriophage populations undergo different life cycles depending 
on the kind of infection cycle and mode of replication they use to carry their genome 
into the host (Marsh & Wellington, 1994; Rao, 2006; Courchesne et al., 2009). 
Following the initial infection, there are two categories of bacteriophages; lytic 
(virulent) or lysogenic (temperate). Lytic bacteriophages lyse the cells they infect 
and produce phage progeny for further infection while lysogenic bacteriophages 
establish an unapparent and continual infection without killing the host cell (Rao, 
2006; Chaudari, 2014). Furthermore, virulent phages can only replicate by means of 
lytic cycle, while temperate phages are able to replicate in both lytic and lysogenic 
cycles. A key difference between lytic and lysogenic cycles is that the lytic phage 
multiplies the viral DNA by a production of infectious individual phage progeny and 
infects other cells while the lysogenic phage reproduces the viral DNA by 
prokaryotic production (Lodish et al., 2008).  
 
 
 The lytic cycle is one of the two reproductive cycles in which phage 
multiplies and ultimately ends in the death of the infected host cell by bursting and 
releasing virions. Lytic phages only undergo virulent infection and destroy the host 
cells as a normal part of their life cycle (Mayer, 2010). Subsequent to infecting the 
host cell, the virulent phages typically proceed with immediate replication of the 
virion prior to produce large numbers of new viruses (Rao, 2006). 
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 As in Figure 2.3, the first stage of lytic infection is the penetration in which 
phage enters the host cell and culminating in the mRNA biosynthesis (Hanlon, 
2007). The attachment of phage usually occurs through the interaction of the phage 
tails with variety of cell membrane surface components (Kropinski, 2006; Dimmock 
et al., 2007; Hanlon, 2007). After infection, the viral nucleic acids are copied by the 
host cell to produce necessary proteins (Kropinski, 2006). Basically, early mRNA is 
produced by transcription of viral genome using host cell RNA polymerase (Hanlon, 
2007). The synthesized mRNAs are then translated by host cell ribosomes into 
proteins such as the capsid or tail proteins. In general, lytic phages take over the cell 
biosynthetic machinery by destroying the host genome and utilizing nucleotides in 
phage DNA replication (Kropinski, 2006). As soon as the nucleic acid is injected, the 
phage cycle is followed by the synthesis of phage components, late proteins, 
assembly and mature phage (Rao, 2006). Due to the accumulation of the phage 
particles within the host, the cell capacity is full and consequently bursts open the 
cell wall (Rao, 2006; Chaudari, 2014). Hence, this process is known as lysis and 
release phase (Rao, 2006; Mayer, 2010). 
 
 
 Similar to that of lytic cycle, lysogenic (temperate) phages begin the cycle 
with the adsorption of nucleic acids upon entering the host cell (Campbell & Reece, 
2005; Fortuna et al., 2008). In this cycle alternatively, phages do not necessarily 
enter a lytic cycle but instead results in the integration of the phage DNA into the 
host chromosome forming a non-infectious phage genetic material called prophage 
(Figure 2.3) (Grabow, 2001; Hanlon, 2007, Mayer, 2010; McNair et al., 2012). Most 
of the phage genomes are capable of maintaining their chromosome in stable, 
dormant or silent within host cell during this period (Mayer, 2010). Furthermore, in 
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Figure 2.3: The lytic and lysogenic pathways of bacteriophage (Harper, 2011). 
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this quiescent state, the genetic material is not transcribed but instead replicated 
simultaneously with the bacterial DNA in the cytoplasm of host cell without killing it 
(Grabow, 2001; Hanlon, 2007; Fortuna et al., 2008; Mayer, 2010). As the host cell 
reproduces, the prophage is copied and this integrated genetic material is transmitted 
to the daughter cells accordingly to each successive cell division (Mayer, 2010). 
Subsequently, each daughter cell may continue several rounds of replication for 
many generations with the prophage existing in every cell (Hanlon, 2007).  
 
 Occasionally, these lysogens are able to remain in dormant state until they 
become active through induction (Campbell & Reece, 2005). Lysogenic phages can 
be spontaneously directed to the lytic cycle by subjecting them to adverse conditions 
or stress such as dessication, ultraviolet light (UV) irradiation, mutagenic agent 
exposure and environmental stressors (Rao 2006; Fortuna et al., 2008; McNair et al., 
2012). These conditions trigger the termination of lysogenic state which eventually 
causes cell lysis and initiates release of progeny phages (Grabow, 2001; Rao, 2006; 
Hanlon, 2007).  
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2.2.2 Phage history  
 
 The discovery of phages could be traced back to the late 1910’s. In 1915, 
Frederick William Twort, a British pathologist was the first one who independently 
discovered the antibacterial potential of phages and later by the French-Canadian 
microbiologist, Felix d’Herelle in 1917 at the Pasteur Institute, Paris.  Both pioneer 
researchers had given an account of a filterable and transmissible entity which able to 
kill bacteria culture and claimed that specific bacterial growth could be inhibited by 
the addition of bacteria-free filtrates (Grabow, 2001; Gravitz, 2012; Lavigne & 
Robben, 2012). 
 
 It was d’Herelle who named the virus as “bacteriophage” or “bacteria eater”, 
derived from the Greek word “phagein” meaning “to eat” (Gravitz, 2012).  In 
addition, he was the first scientist to apply bacteriophage against bacterial infections 
and this concept is also known as phage therapy. Since then, phage therapy was 
extensively developed in many places (Kutateladze & Adamia, 2008). Regardless of 
the intensive use, this treatment and clinical applications were not completely 
accepted and subsequently abandoned in the West due to the emergence of 
antibiotics in the 1940s (Nishikawa et al., 2008).  
 
2.2.3 Phage distribution 
 
 Phages are the most numerous entities in the biosphere (McGrath & Sinderen, 
2007; Fortuna et al., 2008; Liao et al., 2011).  It is conservatively estimated that the 
total number of phages worldwide to be in the range of 10
30
 to 10
31
, that is equal to 
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100 million to 1 billion phage particles exist globally (Kropinski, 2006; Hanlon, 
2007; Courchesne et al., 2009; McNair et al., 2012).  Thus, they are approximately 
ten times more diverse than bacteria making them the most abundant in microbial 
communities (Marsh & Wellington, 1994; Kropinski, 2006; Hanlon, 2007; McNair et 
al., 2012). Out of this estimation, only a small fraction which is less than ten 
thousands of them has been identified so far (Courchesne et al., 2009; McNair et al., 
2012). Therefore, there are enormous numbers of phages have yet to be discovered 
(Hanlon, 2007). 
 
2.2.4 Phage morphology 
 
 The simplest morphology seen in phages is similar to other viruses that they 
have capsids protecting the nucleic acids (Hanlon, 2007).  As seen in other viruses, 
certain phages could have protrusion proteins on the surface as well.  Yet, there are 
phages with long tails and present of appendages (Mayer, 2010; Chaudari, 2014).  A 
typical head and tail phage is shown in Figure 2.4 with size in the range of 20-200 
nm in length and 80- 100 nm in width (Rao, 2006; Mayer, 2010).  
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Head/Capsid 
Baseplate 
Tail 
Tail fiber 
Neck 
Figure 2.4: A typical phage structure (Miller et al., 2003). 
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2.2.5 Phage as biological control agent 
 
 Following the discovery of phages, the first known antibacterial potential of 
bacteriophage was recognized by Felix d’Herelle since 1919, against dysentery, 
cholera and bubonic plague (Clark & March, 2006; Kutateladze & Adamia, 2008; 
Nishikawa et al., 2008). Since then, the use of phages had generated a flurry of 
interest in modern medical industry in Europe (Clark & March, 2006; Dublanchet, 
2007). 
 
 One primary application of phage is as bio-control agent. The biological 
control application of phage is generally referred to the process of applying lytic 
phages for the treatment of infectious diseases caused by pathogenic bacteria or also 
known as phage therapy (Clark & March, 2006; Dublanchet, 2007; Uchiyama et al., 
2008). Phages are the natural enemies of bacteria which selectively attacks their 
specific hosts (Hagens & Loessner, 2007). This unique characteristic is essentially 
important as a bio-control of bacterial infections to target and kill diseases-causing 
bacteria without damaging the natural bacterial flora (Capparelli et al., 2005; Hagens 
& Loessner, 2007; Uchiyama et al., 2008). 
 
 However, since the implementation of antibiotics in the 1940s, the research 
and clinical application of phage therapy were largely abandoned by most western 
scientists after World War II (Tanji et al., 2005; Clark & March, 2006; Hanlon, 
2007; Fortuna et al., 2008; Kutateladze & Adamia, 2008; Nishikawa et al., 2008; 
Vinodkumar et al., 2008). 
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  Due to recent increases in antibiotic-resistant bacterial strains, the therapeutic 
exploitation of phages has once again received renewed interest as alternative 
treatment (Goodridge et al., 2003; Tanji et al., 2005; Clark & March, 2006; 
Kropinski, 2006; Dublanchet, 2007; Hanlon, 2007; Nishikawa et al., 2008; 
Vinodkumar et al., 2008; Courchesne et al., 2009) and/or synergistic approach to 
battle against bacterial infections (Ryan et al., 2012). Thus, many pharmaceutical 
companies are putting a lot of efforts into phage technology through investment, 
rigorous research and development activities in favor of therapeutic phage 
preparations (Clark & March, 2006; Hanlon, 2007).  
 
 In addition, with the recent advances in molecular biology and gradually 
improved knowledge of phage biology have created more opportunities for second-
time success in phage therapy (Kudva et al., 1999; Courchesne et al., 2009). 
Furthermore, it has become apparent that phages offer numerous unique advantages 
over the use of conventional antibiotic therapy (Hanlon, 2007), such as, phage 
specificity in destroying drug-resistant bacteria that minimally cause disturbance to 
normal beneficial flora, quickly producing new phages in response to the appearance 
of phage-resistant bacteria compared to inability of antibiotics to respond to bacteria 
resistant and lower production cost since phages are easily discovered from various 
environments (Courchesne et al., 2009). 
 
 Eliava Institute of Bacteriophage, Microbiology and Virology, located in 
Tbilisi, the former Soviet Union has been and still the primary manufacturer of phage 
products in the world.  Besides, the main focus area of Eliava Institute appears to be 
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the world authority in research and development of phages for pathogenic bacteria 
control (Hanlon, 2007). 
 
 2.3 Escherichia coli bacteria host 
 
 Escherichia coli is a Gram-negative, robust and rod-shaped bacterium from 
the family Enterobacteriaceae (O’Flynn et al., 2004; Naylor et al., 2005; Vogt & 
Dippold, 2005). This bacterium was previously discovered in 1885 by a German 
paediatrician, Theodor Escherich (Goodridge et al., 2003; Naylor et al., 2005). This 
species is the most abundant facultative anaerobe that is usually found in the lower 
intestinal tracts of human, free-living animals and warm-blooded organisms 
(Schroeder et al., 2002; Goodridge et al., 2003; Naylor et al., 2005; Vogt & Dippold, 
2005). The bacterium is also found in water, foods and soil due to contamination by 
fecal or during animal slaughter (Schroeder et al., 2002).    
 
 
2.3.1 Significance of E. coli O157:H7 infections 
 
 
 Studies have shown that food borne diseases in humans are caused by certain 
serotypes of E. coli strains producing Shiga toxin, for examples E. coli O157:H7 and 
E. coli O104:H4. Serotypes are the group of cells distinguished by their shared cell 
surface antigens. The “O” in the name refers the cell wall (somatic) antigen number, 
while the “H” refers the flagella antigen (Baron, 1996).  These antigens are essential 
for phage infection as phage recognizes them prior to attachment (Kropinski, 2006). 
These E. coli strains are also described as ‘Shiga toxin-producing’ E. coli (STEC) by 
producing Shiga-like toxins (Stx) I and II (Tanji et al., 2005; Liao et al., 2011). Shiga 
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toxin is the most important E. coli pathogenic factor that is responsible for the 
bacterial infection and pathogenicity.  Moreover, these harmful strains are also 
known as the primary etiologic agent of urinary tract infections (UTIs) in humans 
and animals. These infections are one of the most common bacterial diseases in 
humans (Nishikawa et al., 2008).  
 
 The spread of infectious diseases caused by food borne bacterium such as 
Campylobacter, Salmonella, E. coli and Listeria remains as problems to public 
health (Hagens & Loessner, 2007).  In fact, the numbers of cases of food borne 
diseases have been increasing dramatically including diseases caused by E. coli 
O157:H7 (Currie et al., 2007).  This notorious E. coli O157:H7 is also referred as an 
enterohaemorrhagic strain of Escherichia coli (EHEC).  
 
  E. coli O157:H7 has been a main food safety concern due to its low infective 
dose in humans with only one hundred cells (Tanji et al., 2004; Raya et al., 2006; 
Liao et al., 2011). This low infectious dose of high virulence of E. coli O157:H7 
could cause severity of infections that may seriously result in death due to 
hemorrhagic colitis with highest incidence of reported cases occurring mostly in 
children aged less than 15 years and elderly (Galland et al., 2001; Nishikawa et al., 
2008).  Meanwhile, the World Health Organization (WHO) estimates that five 
millions children die each year due to acute diarrhea. Indeed, E. coli O157:H7 has 
been claimed as one of major cause of childhood diarrhea in developing and 
threshold countries (Hanlon, 2007). 
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 The Centers for Disease Control and Prevention (CDC) estimated that there 
were approximately 265,000 STEC infections occur each year in the U.S.A and out 
of this estimation, 36% were caused by E. coli O157:H7 with 73500 illnesses, 2100 
hospitalizations and 60 deaths (Schroeder et al., 2002; National Institute of Allergy 
and Infectious Diseases, 2011).  CDC has claimed that multiple food borne diseases 
outbreaks of E. coli O157:H7 have been primarily associated with consumption of 
undercooked ground beef and contaminated bovine products such as unpasteurised 
milk (Goodridge et al., 1999; Kudva et al., 1999; Schroeder et al., 2002; O’Flynn et 
al., 2004; Capparelli et al., 2005; Naylor et al., 2005; Abuladze et al., 2008; Viazis et 
al., 2011). Other food products that have epidemiologically implicated in the 
outbreaks include fruits, fresh vegetables, salads, and salami contained with 
preserved ready-to-eat beef (Goodridge et al., 1999; Capparelli et al., 2005; 
Abuladze et al., 2008).  For examples, the unintentional outbreaks in the U.S 
between 1992 and 1993 were linked to the undercooked ground beef consumption at 
fast food outlets (Goodridge et al., 1999).  Apart from that, several outbreaks have 
associated with lettuce which was one of the sources of contamination (Kudva et al., 
1999). In addition, according to Abuladze et al. (2008), the outbreak of 2006 in the 
U.S. has been linked to contaminated spinach whereas in Japan; radish sprouts was 
the main source of contamination in the massive 1996 outbreak (Kudva et al., 1999). 
Abuladze et al. (2008) has also revealed that the contaminated radish sprouts were in 
fact served in school lunches and thus largely affected 8,000 children. 
 
 
E. coli O157:H7 infections of have serious complications in humans such as 
thrombotic thrombocytopenic purpura (TTP), acute renal diseases and fatal bloody 
diarrhea which develops to a range of potentially life-threatening conditions from 
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hemorrhagic colitis (HC) occasionally to a type of kidney failure known as 
hemolytic-uremic syndrome (HUS) (Tanji et al., 2004; Capparelli et al., 2005; 
Hagens & Loessner, 2007). Besides, current treatment of E. coli O157:H7 human 
infections showed high prevalence of resistance towards standard antibiotics 
example, ampicilin, tetracycline, cephalothin and sulfamethoxazole (Schroeder et al., 
2002). In fact, the use of some antibiotics such as fluoroquinolones for this infection 
is not recommended in the U.S. as it may potentially induce Shiga-toxin encoding 
bacteriophages in vivo and release Shiga toxin in the intestinal tract (Galland et al., 
2001; Schroeder et al., 2002).  Due to the emergence and raising cases of antibiotic 
resistance of E. coli O157:H7, natural control strategies have received growing 
demand and attention including the application of phage (Coffey et al., 2011; Park et 
al., 2012).  Hence, E. coli
 
O157:H7-specific phages could be used in phage therapy 
to deal with this resistance by infecting and lysis the pathogen. 
 
 The transmission of E. coli O157:H7 may occur from bovine feces onto meat 
during slaughter or milking as direct fecal contact may contaminate food, water and 
person-to-person (Kudva et al., 1999; O’Flynn et al., 2004; Naylor et al., 2005). 
Tracing the principal source of food borne outbreaks, reveals that the gastrointestinal 
tracts of ruminants particularly cattle and sheep have been discovered as major 
asymptomatic reservoirs of this pathogen (Kudva et al., 1999; O’Flynn et al., 2004; 
Tanji et al., 2004; Capparelli et al., 2005; Naylor et al., 2005; Raya et al., 2006).  
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2.3.2 E. coli O157:H7-specific virulent phages 
 
 Previous studies have discovered over fifty E. coli O157-specific phages that 
efficiently infect and cause lysis to E. coli O157 cells (Table 2.2) (Kudva et al., 
1999; Raya et al., 2006; Villegas et al., 2009; Liao et al., 2011;  Kim et al., 2013; 
Kropinski et al., 2013; Shahrbabak et al., 2013).  Among these E. coli O157-specific 
phages, only twenty four of them (Kropinski et al., 2013) were found to be highly 
effective against E. coli O157:H7 cells (studied from previous literatures). However, 
the available information related to the biology, molecular biology and other 
characteristics of most of these phages are still lacking (Kropinski et al., 2013). 
 
 Table 2.2 List of E. coli O157 and E. coli O157:H7 -specific phages. 
 
 
 
Bacteria Phage  References 
E. coli O157 38, 39, 41, 42, AR1, Bo-21, Av-05, 
SP21, Av-06, Av-08, CA933P, CA911, 
MFA933P, CA9311 MFA45D,  wV8, 
CBA65, CEV1, CEV2, CSLO157, 
DC22, e4/1c, e11/2, ECA1, ECB7, 
ECML-4, ECML-117, ECML-134, 
JK06, KH1,KH4, KH5, LG1, φV10, 
ϕD, PBECO 4, PhaXI, PP01, PP17, 
Rv5, SFP10, SH1, SP15, SP21, SP22, 
vB_EcoM_CBA120(CBA120), 
bV_EcoS_AKFV33(AKFV33), and 
vB_EcoS_Rogue1 (Rogue1) 
 
Kudva et al., 1999; 
Raya et al., 2006; 
Villegas et al., 2009; 
Liao et al., 2011;  
Kim et al., 2013;  
Kropinski et al., 
2013; Shahrbabak et 
al., 2013. 
E. coli O157:H7 AKFV33, AR1, CBA120, CEV1, 
ECML-4, ECML-117, ECML-134, 
e4/1c, e11/2, KH1, KH4, KH5, LG1,  
ϕD, PBECO 4, PhaXI, PP01, PP17, 
Rogue1, Rv5, SH1, SFP10, SP15 and 
wV8  
 
Shahrbabak et al., 
2013. 
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2.4 Comparison of phages infecting E. coli O157:H7 
 
 Among the listed E. coli O157:H7-specific phages (Table 2.2), only a few of 
them were well-studied (Kropinski et al., 2013) previously and the information on 
their sources of isolation, morphological and genome characteristics, and their lytic 
activities were obtained from previous literatures. Thus, this information was 
described and compared in the following subsections. 
 
2.4.1 Sources and regions of isolation  
 
 Phages are remarkably abundant in our environment, circulating among 
human population. They are ubiquitous and reside in all reservoirs occupied by 
bacteria including intestines, food or soil. Examples of their natural sources are 
sewage, water, and feces from animals or humans. Therefore, these sources are 
principally used for phage isolation (Morita et al., 2002).  
 
 E. coli O157:H7-specific phages were isolated from different types of 
samples collected at various locations. Table 2.3 shows the collected samples and 
their original locations for each phage. From Table 2.3, most of phages infecting E. 
coli O157:H7 had been isolated from fecal and sewage samples. However, the 
pattern of prevalence showed the abundance of phages was highest in feces 
compared to sewage. This is due to the fact that feces of ruminants are considered as 
a rich source of phage infecting E. coli O157:H7 because ruminants are the natural 
niche for EHEC (Viazis et al., 2011). 
